Company Overview - Tianyu Biological (SH 603717) announced on December 19 that its fifth board meeting was held to discuss the termination of fundraising investment projects and the use of remaining funds for permanent working capital [1] Financial Performance - For the year 2024, Tianyu Biological's revenue composition is as follows: pig farming accounts for 72.29%, landscape ecological engineering for 19.78%, red yeast product manufacturing for 3.89%, photovoltaic new energy for 3.17%, and other businesses for 0.87% [1] Market Position - As of the report, Tianyu Biological has a market capitalization of 2.3 billion yuan [1]

Group 1 - The actual controller of Tianyu Biological, Mr. Luo Weiguo, holds 37,251,829 shares, accounting for 12.84% of the total share capital of the company [1] - Mr. Luo has released 2,252,977 shares from freezing, which is 6.05% of his holdings and 0.78% of the total share capital [1] - After the release, approximately 12.12 million shares remain frozen, representing 4.18% of the total share capital [1] Group 2 - For the year 2024, the revenue composition of Tianyu Biological is as follows: pig farming accounts for 72.29%, landscaping ecological engineering for 19.78%, red yeast product manufacturing for 3.89%, photovoltaic new energy for 3.17%, and other businesses for 0.87% [1] - As of the report, the market capitalization of Tianyu Biological is 2.4 billion yuan [1]

Group 1 - The company Tianyu Biological (SH 603717) announced on October 22 that its fifth board meeting was held, discussing the proposal for the 2025 A-share issuance plan [1] - For the year 2024, the revenue composition of Tianyu Biological is as follows: pig farming accounts for 72.29%, landscape ecological engineering for 19.78%, red yeast product manufacturing for 3.89%, photovoltaic new energy for 3.17%, and other businesses for 0.87% [1] - As of the report date, Tianyu Biological has a market capitalization of 2.6 billion yuan [1]

Company Overview - Tianyu Biological (SH 603717) announced on September 28 that its fourth board meeting was held, discussing the cancellation of the supervisory board, adjustment of board members, and amendments to the company’s articles of association [1] Financial Performance - For the fiscal year 2024, Tianyu Biological's revenue composition is as follows: pig farming accounts for 72.29%, landscaping ecological engineering for 19.78%, red yeast product manufacturing for 3.89%, photovoltaic new energy for 3.17%, and other businesses for 0.87% [1] Market Position - As of the report, Tianyu Biological has a market capitalization of 2.5 billion yuan [1]

Group 1 - Tianyu Biological announced the resignation of its Vice Chairman and President, Shi Dongwei, effective August 25, 2025, due to personal retirement plans and to support the company's actual controller, Luo Weiguo, in managing the company [1] - After resigning as President, Shi Dongwei will continue to serve as Vice Chairman until the current board term ends on October 24, 2025, and will fulfill his duties as per legal and regulatory requirements [1] - For the year 2024, Tianyu Biological's revenue composition is as follows: pig farming accounts for 72.29%, landscaping ecological engineering for 19.78%, red yeast product manufacturing for 3.89%, photovoltaic new energy for 3.17%, and other businesses for 0.87% [1] Group 2 - As of the report, Tianyu Biological has a market capitalization of 2.6 billion yuan [2]

Group 1 - Tianyu Biological (SH 603717) held its 43rd board meeting on August 25, 2025, to review the proposal regarding the conditions for issuing A-shares to specific targets [1] - For the year 2024, the revenue composition of Tianyu Biological is as follows: pig farming accounts for 72.29%, landscape ecological engineering for 19.78%, red yeast product manufacturing for 3.89%, photovoltaic new energy for 3.17%, and other businesses for 0.87% [1] - As of the report date, Tianyu Biological has a market capitalization of 2.6 billion yuan [1] Group 2 - The pet industry is experiencing a significant boom, with a market size of 300 billion yuan, leading to a surge in stock prices for related companies [1]